# FDA Inspection 825603 - Sciegen Pharmaceuticals Inc - April 02, 2013

Source: https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/06c53fa4-272f-4d80-96e6-6113b7bce4e2
Source feed: FDA_Inspections

> FDA Inspection 825603 for Sciegen Pharmaceuticals Inc on April 02, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 825603
- Company Name: Sciegen Pharmaceuticals Inc
- Inspection Date: 2013-04-02
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1297968 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/d3faa575-0975-4a44-9f38-ff5d4d5c76a1)
- [FDA Inspection 1297968 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/dbc62b1e-da3f-4e51-b99e-d9e5f6698380)
- [FDA Inspection 1229682 - 2024-02-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/c0bb89dd-507e-46db-a766-fad3d39acd40)
- [FDA Inspection 1204858 - 2023-04-21](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/78debf30-0ef4-42cc-be44-6bb8ef0669d0)
- [FDA Inspection 1178870 - 2022-09-02](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/2cf09840-dbd9-4665-b3f8-2df1a91433da)

Company: https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c